Core Scientific, Inc./tx (CORZ) /
The cash flow of Core Scientific, Inc./tx over the past 6 years
Chart Core Scientific, Inc./tx: operating cash flow, capital expenditures, free cash flow, fiscal 2020–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Core Scientific, Inc./tx's operating cash flow was $278.25M and its capital expenditures $729M, leaving free cash flow of -$450.75M. Free cash flow was above zero in 1 of the 6 years shown. It ranged from -$450.75M in fiscal 2025 to $48.95M in fiscal 2023. Capital expenditures were highest in fiscal 2025, at $729M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $278.25M | $729M | -$450.75M |
| 2024ended Dec 31, 2024 | $42.9M | $94.96M | -$52.06M |
| 2023ended Dec 31, 2023 | $65.11M | $16.16M | $48.95M |
| 2022ended Dec 31, 2022 | $205.19M | $383.98M | -$178.79M |
| 2021ended Dec 31, 2021 | -$56.73M | $0 | -$56.73M |
| 2020ended Dec 31, 2020 | -$23.77M | $0 | -$23.77M |
Fiscal years as Core Scientific, Inc./tx reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Core Scientific, Inc./tx
- The revenue of Core Scientific, Inc./tx
- The profitability of Core Scientific, Inc./tx
- The debt of Core Scientific, Inc./tx
- All of Core Scientific, Inc./tx's financials, charted
Companies of a similar size
- INDVIndivior Pharmaceuticals, Inc.
- APLEAPPLE HOSPITALITY REIT, INC.
- LOPEGRAND CANYON EDUCATION, INC.
- MTHMeritage Homes Corporation
- CRVLCORVEL CORPORATION
Not investment advice. This page shows what Core Scientific, Inc./tx filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.